Table 1.
First author | Age, gender | Valve affected | Organism | Risk factors | Culture source | Antibiotics | Disease duration, months | Antibiotic duration, weeks | Outcome |
---|---|---|---|---|---|---|---|---|---|
Al-Benwan11 | 54, male | Mitral, native | Mycobacterium abscessus | Hepatitis C, alcoholic cirrhosis, ESRD, haemodialysis | Blood, catheter-tip | Clarithromycin and tigecycline | 5.5 | 7 | Died |
Altmann12 | 45, male | Aortic, prosthesis | M. abscessus | Previous endocarditis, rheumatic disease, recent aortic valve replacement | Blood, prosthesis | Lincomycin+cloxacillin | 4.5 | 8 | Died |
Liebeskind13 | 35, male | Mitral, native | M. abscessus | NA | Blood, CSF, BM | Clarithromycin+imipenem | 7 | 10 | Died |
Tsai14 | 29, male | Tricuspid, native | M. abscessus | IV drug use, previous endocarditis | Blood, sputum | Clarithromycin+amikacin+ciprofloxacin | 9 | 14 | Alive |
Viscidi15 | 55, male | Mitral, prosthesis | M. abscessus | Rheumatic heart disease | Blood, urine, BM, sputum, wound | Amikacin, erythromycin, ethionamide | 5 | 4 | Died |
Wallace3 | 53, male | Prosthesis | M. abscessus | NA | Blood | NA | NA | NA | Died |
Wallace3 | 50, male | Prosthesis | M. abscessus | NA | Blood | NA | NA | NA | Died |
Williamson16 | 29, female | Mitral, native | M. abscessus | ESRD, haemodialysis, renal transplant, anaemia, corticoid immunosuppression | Blood | Imipenem, clarithromycin, moxifloxacin | 1.5 | 6.5 | Died |
Citro17 | 74, male | Mitral, native | Kocuria kristinae | Diabetes, hypertension, foot ulcer | Blood | Ampicillin–sulbactam+gentamicin | 1 | 3 | Died |
Lai7 | 89, female | NA | K. kristinae | Ischaemic bowel disease status post surgery, TPN | Blood | Vancomycin+teicoplanin | NA | NA | Alive |
Srinivasa18 | 35, male | Mitral, native | K. rosea | Rheumatic mitral regurgitation | Blood | Gentamicin+ceftriaxone | 2 | 4 | Alive |
Present case | 48, male | Mitral, native | M. abscessus and Kocuria species | IV drug use | Blood, mitral valve | Amikacin+clarithromycin+imipenem | 8 | 24 | Alive |
BM, bone marrow; CSF, cerebrospinal fluid; ESRD, end-stage renal disease; IV, intravenous; NA, not applicable or not available; TPN, total parenteral nutrition.